512217 — Prism Medico and Pharmacy Income Statement
0.000.00%
Last trade - 00:00- IN₹90.59m
- IN₹89.93m
- IN₹6.32m
Annual income statement for Prism Medico and Pharmacy, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 168 | 84.4 | 12.7 | 29.3 | 6.32 |
| Cost of Revenue | |||||
| Gross Profit | 0.955 | -1.84 | 1.3 | 3.64 | 1.83 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 169 | 89.4 | 13.7 | 30.7 | 7.13 |
| Operating Profit | -1.75 | -4.99 | -1.04 | -1.43 | -0.806 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.75 | -4.99 | -1.02 | -0.28 | -0.658 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.3 | -3.7 | -0.764 | -0.346 | -0.487 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.3 | -3.7 | -0.764 | -0.346 | -0.487 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.3 | -3.7 | -0.764 | -0.214 | -0.487 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.214 | -0.61 | -0.126 | -0.035 | -0.08 |